drugset / Trial / NCT01637155

Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After Standardization

NCT01637155

Phase 2 Unknown 44 enrolled Hospital Clinic of Barcelona
NaSingle-groupOpen-labelTreatment

Summary

Set the pattern of vitamin D supplementation in obese patients undergoing bariatric surgery in deficit of vitamin D. Patients receive a single oral dose of vitamin D, during the 28 days will be done a kinetic curve. Then and over the next 3 months, levels are normalized. Once normalized, will be administered another single oral dose to a second pharmacokinetic evaluation.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 1000 iu Oral
Subject Cholecalciferol Other / unclassified 1200 iu Oral
Subject Cholecalciferol Other / unclassified 2000 iu Oral
Subject Cholecalciferol Other / unclassified 2800 iu Oral
Subject Cholecalciferol Other / unclassified 50000 iu Oral

Indications